Suchergebnisse
Can BMY's First CELMoD Approval Support Its Growth Strategy?
Bristol Myers Squibb BMY recently announced that the FDA has granted accelerated approval to iberdomide in combination with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd).
The regimen
J.B. Hunt Sees Freight Recovery, Intermodal Pricing Upside Into 2027
Key Points
- Interested in J.B. Hunt Transport Services, Inc.? Here are five stocks we like better.
- J.B. Hunt sees an early-stage freight recovery as trucking capacity tightens, demand indicators
Contango ORE Q2 Earnings Call Highlights
Key Points
- Interested in Contango ORE, Inc.? Here are five stocks we like better.
- Manh Choh production is expected to accelerate in the second half of 2026 as mining shifts to higher-grade
Solana Company (HSDT) Reports Q2 Loss, Lags Revenue Estimates
Solana Company (HSDT) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $79.73 per share a year ago. These figures
Vivos Therapeutics, Inc. (VVOS) Reports Q2 Loss, Lags Revenue Estimates
Vivos Therapeutics, Inc. (VVOS) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $0.55 per share a year ago. These
Cerenome (CNSY) Reports Q2 Loss, Misses Revenue Estimates
Cerenome (CNSY) came out with a quarterly loss of $1.31 per share versus the Zacks Consensus Estimate of a loss of $0.96. This compares to a loss of $0.25 per share a year ago. These figures are
Sidus Space Q2 Earnings Call Highlights
Key Points
- Interested in Sidus Space, Inc.? Here are five stocks we like better.
- Second-quarter revenue fell 54% to approximately $583,000, while the net loss narrowed to $4.8 million; adjusted
Movano Q2 Earnings Call Highlights
Key Points
- Interested in Movano Inc.? Here are five stocks we like better.
- Corvex reported $3.8 million in Q2 2026 revenue, all from its AI platform and services business, while contracted
Solana Q2 Earnings Call Highlights
Key Points
- Interested in Solana Company? Here are five stocks we like better.
- Revenue reached $2.5 million in Q2 2026, entirely driven by staking rewards, while the company posted a $30.3
New Era Energy & Digital, Inc. (NUAI) Reports Q2 Loss, Misses Revenue Estimates
New Era Energy & Digital, Inc. (NUAI) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.21 per share a year ago
HIVE Digital Technologies (HIVE) Reports Q1 Loss, Lags Revenue Estimates
HIVE Digital Technologies (HIVE) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to a loss of $0.06 per share a year ago
InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates
InspireMD, Inc. (NSPR) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.26 per share a year ago. These figures
Barfresh Food Group Inc. (BRFH) Reports Q2 Loss, Lags Revenue Estimates
Barfresh Food Group Inc. (BRFH) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.06 per share a year ago. These
Prairie Operating Co. (PROP) Q2 Earnings Top Estimates
Prairie Operating Co. (PROP) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.18 per share a year ago
Catch the Monkey 29.08.2026
Catch the Monkey 29.08.2026
Flexible Solutions International Inc. (FSI) Reports Q2 Loss, Misses Revenue Estimates
Flexible Solutions International Inc. (FSI) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of $0.01. This compares to earnings of $0.15 per share a year ago
NRx Pharmaceuticals, Inc. (NRXP) Reports Q2 Loss, Misses Revenue Estimates
NRx Pharmaceuticals, Inc. (NRXP) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.98 per share a year ago
Netflix: Ackman baut mit 3,15 Millionen Aktien auf
Pershing Square Capital Management unter der Leitung von Bill Ackman hat eine neue Beteiligung…
Der Beitrag Netflix: Ackman baut mit 3,15 Millionen Aktien auf erschien zuerst auf kapitalmarktexperte
